Open Access Open Access  Restricted Access Subscription Access

Functional Overview of Process Validation of Tablets - A Critical Review


Affiliations
1 Department of Quality Assurance, Krupanidhi College of Pharmacy, #12/1, Chikkabellandur, Carmelaram Post, Varthur Hobli, Bangalore - 560035, KA, India
 

Purpose: Validation is a main tool in achieving and maintaining the quality and safety of the final product as per cGMP(current Good Manufacturing Practice). The purpose of this present work is to give introduction, general overview and how to plan, develop, execute process validation of pharmaceutical manufacturing process especially tablet manufacturing process.

Approach: When we consider any product, quality is always an imperative pre requisite hence a highest quality levels must be included in the manufacturing of the drug.

Findings: To assure the identity, purity, safety, efficacy and also maintaining the quality of final product process validation is the key element. Three consecutive batches were considered to execute the process validation activity.

Conclusion: Process validation is a major requirement of cGMP's regulation. Process validation is a key element to maintain product quality, safety, identity and efficacy.


User
Notifications
Font Size


  • Aulton, M. E. "the science of dosage form design, Churchill Livingstone, London." (2002): 322-334.
  • European Commission, Qualification and Validation, Annex 15 to the EU guide to GMP. Brussels, 2001,6.
  • Committee on specifications for pharmaceutical preparations. Good manufacturing practice for pharmaceutical products. WHO technical report series no. 82. Geneva: world health organization, 1992,p.14-79.
  • Herbert A. Lieberman, Leon Lachman, Joseph B. Schwartz, Pharmaceutical Dosage Forms Tablets, second edition, volume 3, Marcel Dekker. Inc, New York, 1990, 417-447.
  • Rockville MD. Guideline on General Principles of Process Validation. US Food and Drug Administration., US FDA. 1987.
  • Nandhakumar L, Dharmamoorthy G, Rameshkumar S, Chandrasekaran S. An overview of pharmaceutical validation: Quality assurance view point. IJRPC. 2011;1:1003-4.
  • Kelley BD. Identification and establishment of operating ranges of critical process variables. Biopharmaceutical Process Validation, Marcel Dekker, New York. 2000 Apr:29-60.
  • Dholakia SP, Valiya AP, Thakar TM, Patel JS, Patel MM. Minireview: Process Validation as Essential Tool in Pharmaceutical Industry.
  • Sharma V, Seth N. Pharmacy Review & Research
  • Paruchuri R, Trivedi S, Pavuluri G. Prasanthi B and Senthil Kumar M. Process Validation of Finasteride Tablets. International journal of pharmaceutical, chemical and biological sciences. 2012;2(1):11-28.
  • Ajay S, Seema S. International Journal of Research in Pharmacy and Science. Int. J. Res. Pharm. Sc. 2013:12.
  • Jatto E, Okhamafe AO. An Overview of Pharmaceutical Validation and Process Controls in Drug Development. Tropical Journal of Pharmaceutical Research. 2002;1(2):115-22.
  • Agalloco JP. Practical consideration in retrospective validation. Pharm tech. 1983 Jun;7(88):90.
  • Mayer RJ. Validation of Product and Process, PPMA. InSeminar on Validation of solid Dosage form Processes. Atlanata May–1980.
  • Jena S, Arjun G, Kumar DS, Vinod KR, Banji D. Industrial process validation of solid dosage forms-An overview. Int J Pharm Sci Rev Res. 2010 Sep;4(2):145-54.
  • Dashora K, Singh D, Saraf S. Validation-the essential quality assurance tool for pharma industries. Cited from www. pharminfo. net. 2005 Sep;3:45-7.
  • Chitlange SS, Pawar AS, Pawar HI, Bhujbal SS, Kulkarni A. A review on validation. Cited from http://www. pharmainfo. net/reviews/validation. 2006;4:318-20.
  • Nash, R. A., Wachter, A. H., Pharmaceutical Process Validation, Vol.129, An International 3rd Edition, Revised and Expanded, Marcel Dekker, New York, March 2003, 28-29.
  • WHO G. Good Practices in Manufacturing of Pharmaceutical Products in WHO Expert Committee on Specifications for Pharmaceutical Preparations. Geneva, April. 1992.
  • Tho I, Bauer-Brandl A. Chemometrics (PCA) in pharmaceutics: tablet development, manufacturing and quality assurance. INTECH Open Access Publisher; 2012.
  • Wazade MB, Walde SR, Ittadwar AM. An Overview of Pharmaceutical Process Validation And Process Control Variables of Tablets Manufacturing Processes In Industry. International Journal of Pharmaceutical Sciences and Research. 2012 Sep 1;3(9):3007.
  • Gupta GD, Garg R, Aggarwal S. Guidelines on General Principles of Validation: Solid. Liquid and Sterile dosage forms. 2008;6(1).
  • Nash RA, Wachter AH. Pharmaceutical Process Validation, Vol. 129, An International 3rd Edition, Revised and Expanded, 201-208.

Abstract Views: 183

PDF Views: 66




  • Functional Overview of Process Validation of Tablets - A Critical Review

Abstract Views: 183  |  PDF Views: 66

Authors

Manasa S. Reddy
Department of Quality Assurance, Krupanidhi College of Pharmacy, #12/1, Chikkabellandur, Carmelaram Post, Varthur Hobli, Bangalore - 560035, KA, India
R. Chandramouli
Department of Quality Assurance, Krupanidhi College of Pharmacy, #12/1, Chikkabellandur, Carmelaram Post, Varthur Hobli, Bangalore - 560035, KA, India

Abstract


Purpose: Validation is a main tool in achieving and maintaining the quality and safety of the final product as per cGMP(current Good Manufacturing Practice). The purpose of this present work is to give introduction, general overview and how to plan, develop, execute process validation of pharmaceutical manufacturing process especially tablet manufacturing process.

Approach: When we consider any product, quality is always an imperative pre requisite hence a highest quality levels must be included in the manufacturing of the drug.

Findings: To assure the identity, purity, safety, efficacy and also maintaining the quality of final product process validation is the key element. Three consecutive batches were considered to execute the process validation activity.

Conclusion: Process validation is a major requirement of cGMP's regulation. Process validation is a key element to maintain product quality, safety, identity and efficacy.


References